Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,743,414
+$654,602 QoQ
Shares Held
18,850
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,347
of 4,150 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $22,152,027 across 13 Drug Manufacturers - General names. ABBV ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
24,267 | $8,787,566 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
18,850 | $4,743,414 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,544 | $3,924,904 | |
| 4 | JNJ |
Johnson & Johnson
|
11,083 | $2,814,749 | |
| 5 | LLY |
ELI LILLY & Co
|
1,246 | $1,494,489 | |
| 6 | PFE |
Pfizer Inc
|
7,059 | $169,980 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
577 | $72,898 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
800 | $46,096 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,743,414 | 18,850 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,088,812 | 18,800 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,477,133 | 23,971 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $10,645,746 | 45,978 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $8,487,660 | 45,726 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $9,520,169 | 45,438 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $8,035,238 | 45,218 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $8,688,922 | 43,999 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $7,329,564 | 42,733 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $7,749,265 | 42,555 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,926,587 | 12,432 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,853,113 | 12,432 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,674,963 | 12,432 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,983,040 | 12,443 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,010,913 | 12,443 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,704,332 | 12,699 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,959,988 | 12,797 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,155,576 | 13,297 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,140,809 | 15,811 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,725,488 | 15,996 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,801,789 | 15,996 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $1,673,254 | 15,616 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $1,271,018 | 14,511 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,261,711 | 12,851 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $596,262 | 7,826 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||